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Regulation of Iron-Related Molecules In the Rat
Hippocampus: Sex- and Age-Associated Differences
Srinivasarao Thulluri 1·3*, Miaozong Wu 2·3A*, Eric R. Blough 2·3·5, Nandini D.P.K. Manne 2·3,
Ashley B. Litchfield\ Bin Wang 1,3

1Department of Chemistry, 2Department of Biological Sciences, 3Center for Diagnostic Nanosystems,
4Department oflnternal Medicine, 5Department of Pharmacology, Physiology and Toxicology,
Marshall University, Huntington, WV 25755
Abstract. Iron accumulation, especially that of free oxidized ferrous iron, has been shown to induce tissue
oxidative damage and contribute to brain aging and the development of neurodegenerative disease. Here
we examine whether sex and advanced age affect the expression of iron-related molecules that participate in
regulating free iron levels (heme oxygenase I (HOI), iron-regulatory protein I (IRPI), and ferritin heavy
chain (FTH)) and whether changes in the expression of these molecules are associated with differences in
the expression of alpha-synuclein (ASN) which is thought to be a critical regulator in the pathogenesis of
neurodegeneration. Using a well-established aging animal model, we demonstrate that the expression of
HOI, FTH, and IRPI mRNAs is higher in the female hippocampus than that observed in male Fischer
344/NNiaHSD x Brown Norway/BiNia (F344BN) rats, regardless of age group. Consistent with these sexassociated alterations in iron-related regulators, the expression of ASN mRNA and protein in the female
hippocampus was lower than that found in male rats. These results suggest a sex-dependent difference in
regulating the expression of molecules involved in iron metabolism and neurodegeneration. A similar finding in humans, if present, may help to shed light on why sex may affect the incidence of neurodegenerative
disorders.

Key words: Sex, Aging, Hippocampus, Heme oxygenase I (HOI), Ferritin, Iron-regulatory protein I
(IRPI), Alpha-synuclein (ASN)

Introduction

It is well known that advanced age is associated
with an elevated risk of developing Parkinson's disease and other neurodegenerative disorders [I, 2].
The mechanism(s) responsible for the pathological
development of these disorders is currently unclear,
but some have suggested that a diminished ability
to respond to stress, elevations in tissue reactive
oxygen species (ROS), and alterations in metal homeostasis may be involved [3-7]. Indeed, age-associated increases in tissue iron are associated with
increased tissue ROS and neuronal damage,
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leading to the hypothesis that the accumulation of
iron in the brain may play a key role in brain aging
and in the development of age-related neurodegenerative disease [I, 8-10]. In addition to aging, it is
also likely that sex plays a role, as males exhibit a
significantly higher incidence of Parkinson's disease than females [2], although no significant differences in iron level have been reported between
male and female brains [II]. Information regarding
how sex may influence the development of age-associated neurodegenerative diseases is currently
sparse.
Heme oxygenase (HO) is a ubiquitously expressed
enzyme responsible for the degradation of heme
[I2]. The expression of HOI is induced by cellular
stress, such as that caused by exposure to UV light,
elevated levels of pro-oxidants, or metal
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dyshomeostasis [13, 14]. Deregulation of HOI has
been linked to several neurodegenerative disorders,
including Alzheimer's disease and Parkinson's disease [15-17]. When released from heme, free iron
can be sequestered by binding with ferritin, a globular protein that contains 24 subunits composed of
two functionally-distinct proteins that are encoded
at various ratios by two different genes: ferritin
heavy chain (FTH, 21 kDa) and ferritin light chain
(FTL, 19 kDa). FTH-rich ferritin predominates in
cells and tissues that have high oxidative respiration because FTH functions to catalyze the oxidation of Fe 2 + [18]. These ferritin molecules not only
function in iron storage, but also help to prevent
increased free-iron-mediated oxidative damage.
Although not well understood, the regulation of
iron metabolism is, at least partially, regulated by
the iron-regulatory proteins (IRPs) [19]. IRPl is the
most abundant isoform that can bind to mRNAs
bearing iron-responsive elements (IREs) and decrease expression of iron-related proteins such as
FTH and FTL [19, 20].
Increased expression of alpha-synuclein (ASN) is
thought to relate to the development of neurodegenerative diseases [21]. Elevated ASN mRNA and
protein expression have been reported in Parkinson's
patients [22-24]. The ASN molecules can aggregate
and form abnormal protein clusters in the Lewy
bodies, a structure commonly found in the brains
of Parkinson's patients [22-25]. Interestingly, an
IRE-like stem-loop structure has been found in the
5' untranslated region (5'UTR) of ASN mRNA
[26, 27], which suggests the possibility of a link between iron dysregulation and the development of
neurodegenerative diseases.
Here we hypothesize that sex and advanced age affect the expression of iron-related molecules, which
in turn alter the expression of alpha-synuclein. It
has been suggested that the hippocampus is more
vulnerable to oxidative damage, and that dopamine denervation in Parkinson's disease is associated with ASN deposition in the hippocampus
[28]. Therefore, we chose to examine how sex and
advanced age affect iron-related molecules and expression of ASN in the hippocampus of Fischer
344/NNiaHSD x Brown N orway/BiNia (F344BN)
rats, a well-established aging animal model [29].

Our findings provide evidence for sex-dependent
differences in the expression of molecules involved
in iron metabolism and neurodegeneration in the
rat hippocampus.

Materials and Methods

Animals. Animal care and use were approved by
the Marshall University Institutional Animal Care
and Use Committee (IACUC approval number
#346), and the "Principles of Laboratory Animal
Care" (NIH publications No. 86-23, revised 1985)
were followed. Male (6- and 33-month-old) and
female (6- and 30-month-old) F344BN rats (n = 6
in each of the 4 groups) were obtained from the
National Institute of Aging (Bethesda, MD).
Animals were housed 2 per cage in a vivarium approved by the American Association of Laboratory
Animal Care. Housing conditions included a 12hour light/dark cycle, with the temperature maintained at 22 ± 2aC as previously outlined [5]. Food
and water were provided ad libitum, and animals
were allowed to recover from shipment for at least
2 weeks before experimentation. Based on rat survival curves obtained from the National Institute
of Aging, the age of a 30-month-old female
F344BN is approximately equivalent to that of a
33-month-old male rat. Six-month-old male and
female rats (n = 6 per group) were used as the adult
controls.

Tissue isolation. The rats were anesthetized by an
intraperitoneal injection of a ketamine-xylazine
(4:1) cocktail administered at 50 mg/kg, and supplemented as necessary for reflexive response as detailed elsewhere [5]. Brains were removed and
rinsed in Krebs solution to remove any superficial
blood. The hippocampus was quickly separated
from the whole brain, blotted dry, and immediately
frozen in liquid nitrogen [30]. Tissue samples were
stored at -80aC until further use.

RNA extraction and real-time quantitative
PCR (RT-qPCR). The hippocampus tissue was homogenized in TRI reagent (Ambion, Austin, TX)
at a ratio of 1 mL of TRI reagent per 100 mg of
tissue, as outlined by the manufacturer. After a 5
minute incubation, the homogenates were centrifuged (12,000 x g for 15 min at 4°C). The supernate
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Inc., Foster City, CA) as previously
outlined [31, 32]. PCR
Table I. PCR primers used to quantify the levels ofHOI, FTH,
reactions were run on an ABI
IRPI, ASN, B-actin, and GAPDH transcripts
7000 Real-Time PCR system
(Applied Biosystems Inc.,
HOI forward primer 5'-TGCTCGCATGAACACTCTG-3'
Foster City, CA) using the
HOI reverse primer 5'-TCCTCTGTCAGCAGTGCCT-3'
following cycling conditions:
FTH forward primer 5'-CTGAATGCAATGGAGTGTGC-3'
50aC for 2 minutes, 95aC for
FTH reverse primer 5'-TCTTGCGTAAGTTGGTCACG-3'
10 minutes, followed by 40
IRPI forward primer 5'-TTGCCGAGCCCTTGGACCCT-3'
cycles at 95aC for 15 seconds
IRPI reverse primer 5'-TCACAGTTCCGAACGGCGGC-3'
and 60aC for 1 minute [31,
ASN forward primer 5'-AGGGAGTCGTTCATGGAGTG-3'
32].
All experiments were reASN reverse primer 5'-CCCTCCACTGTCTTCTGAGC-3'
peated in triplicate using
B-actin forward primer 5'-CAACCTTCTTGCAGCTCCTC-3'
~-actin and glyceraldehyde
B-actin reverse primer 5'-TCTGACCCATACCCACCATC-3'
3-phosphate dehydrogenase
GAPDH forward primer 5'-GGCTCTCTGCTCCTCCCTGTTCT-3'
GAPDH reverse primer 5'-GCCAAATCCGTTCACACCGACCTT-3'
(GAPDH) as an internal control. The forward and reverse
primers (Table 1) were purchased from Integrated DNA
technologies (San Diego,
was collected and mixed with 200 f.!L chloroform
CA). The expression of HOI, FTH, IRPl, and
(Sigma-Aldrich, Inc., St. Louis, MO). After a 10
ASN mRNAs were normalized to the geometric
minute incubation at room temperature, the aquemeans of ~-actin and GAPDH mRNAs, and the
ous phase of the mixed solution was collected via
2-L\.Ct method was used to calculate the relative
centrifugation (12,000 x g for 15 min at 4aC) and
mRNA expression level [31, 32].
then mixed with 500 f.!L isopropanol (SigmaImmunoblotting analysis. Hippocampus protein
Aldrich Inc., St. Louis, MO). RNA pellets were
was extracted via homogenization in Pierce tissue
precipitated (12,000 x g for 10 min at 4aC), washed
protein extraction reagent buffer (T-PER; Thermo
with 75% ethanol, and then dried under vacuum
Fisher Scientific Inc., Rockford, IL) containing
(Eppendorf Vacufuge Model 5301 Vacuum
protease inhibitors (#P8340; Sigma-Aldrich Inc.,
Concentrator, Westbury, NY). After dissolving the
St. Louis, MO) and phosphatase inhibitors
RNA pellet with 50 f.!L of nuclease-free water,
(#P5726; Sigma-Aldrich Inc., St. Louis, MO) as
RNA was quantified at 260 nm using a NanoVue
previously detailed [5, 33]. The total protein conUV-Vis Spectrophotometer (GE Healthcare,
centration of each homogenate was determined usPiscataway, NJ). RNA integrity was confirmed using the Pierce 660 nm protein assay (Pierce,
ing a RNA 6000 Nano Kit and an Agilent 2100
Rockford, IL). Samples containing equal amounts
Bioanalyzer (Agilent Technologies, Santa Clara,
of protein (to a final concentration of 2.0 flglf.!L)
CA). RNA samples were stored at -80aC until
were boiled in SDS-loading buffer (Sigma-Aldrich
further use.
Inc., St. Louis, MO), and then separated on precast
Reverse transcription coupled with RT-qPCR was
10 or 15% SDS-PAGE gels (Lonza Rockland,
used to quantify the relative abundance of HOI,
Rockland, ME) before being transferred to nitroFTH, IRPl, and ASN mRNAs in hippocampus
cellulose membranes as described elsewhere [5, 33].
samples. Complimentary DNA (eDNA) libraries
Gels were stained with RAPID protein reagent
were synthesized using a High Capacity eDNA
(G-Biosciences, St. Louis, MO) to confirm equal
Reverse Transcription Kit (Applied Biosystems
protein loading and the transfer efficiency of proInc., Foster City, CA) as per the manufacturer's inteins onto the membranes.
structions. RT-qPCR was set up using the Power
SYBR Green PCR Master Mix (Applied Biosystems
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Figure I Heme oxygenase I (HOI) mRNA expression in the hippocampus in adult and aged female and male F344BN rats (F-6 and
F-30: 6- and 30-month-old female rats; M-6 and M-33: 6- and
33-month-old male rats). Data are means± SEM (n = 6 per group).
There are gender (p ::::; 0. 05) and age (p ::::; 0. 05) differences, but there
is no interaction between gender and age (p = 0.47). f: age difference
(p ::::; 0.05) within the same gender; *:gender difference (p ::::; 0.05)
within the same age.
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The expression of the target protein
was visualized following incubation of
the nitrocellulose membranes with
ECL Western Blotting reagent (GE
Healthcare Bio-Sciences, Piscataway,
NJ). The amount of target protein
present
was
quantified
using
AlphaEaseFC image analysis software,
and was normalized to the amount of
GAPDH.

Data analysis. Results are presented
as the mean ± SEM. A two-way analysis of variance (ANOVA) followed by a
Student-Newman-Keuls test was performed using the SigmaStat 3.5 statistical program (SPSS Science Inc.,
Chicago, IL) to determine the effect of
sex (male versus female), age (adult
versus aged), and the interaction of sex
x age on both mRNA and protein expression. A value of p::::; 0.05 was considered to be statistically significant.
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The expression of HOI, FTH, and
IRPI mRNAs in rat hippocampus.

The expression of HOI mRNA was
higher in the female hippocampus
Ci
a:: 1
than that observed in the male animals
(p::::; 0.05; Figure 1). The expres0
sion of HOI mRNA in the aged feF-6
F-30
M-6
M-33
male hippocampus was higher than
that in the adult female rats (p::::; 0.05),
Figure 2 Ferritin heavy chain (FTH) mRNA expression in the hippocampus in adult and agedfemale and male F344BN rats (F-6 and
while HOI mRNA expression was
F-30: 6- and 30-month-old female rats; M-6 and M-33: 6- and
unaltered with aging in males (Figure
33-month-old male rats). Data are means± SEM (n = 6 per group).
1). The expression of both FTH and
There is a difference by gender (p ::::; 0. 05), but there is neither an age
effect (p = 0.20) nor an interaction between gender and age (p =
IRPI mRNAs in the female hippo0.86). *:gender difference (p::::; 0.05) within the same age.
campus were higher than in male rats
(p::::; 0.05; Figures 2, 3), and were unaltered with aging in rats of either sex (Figures 2,
To probe for the antigen of interest, the nitrocellu3).
lose membranes were first incubated with an antiThe expression ofASN mRNA in rat hippocamgen-specific primary antibody, followed by incubapus. The expression of ASN mRNA in the female
tion with the appropriate horseradish peroxidase
hippocampus was lower than that observed in ei(HRP)-linked secondary antibody. The primary
ther the adult or aged male rats (p::::; 0.05; Figure 4)
antibody against ASN was purchased from Santa
and was unaltered with aging in rats of either sex
Cruz Biotechnology (Santa Cruz, CA); the
(Figure 4).
GAPDH antibody and HRP-linked anti-rabbit

1a

2

IgG secondary antibody were obtained from Cell
Signaling
Technology
(Danvers,
MA).

The expression ofASN protein in rat hippocampus. The expression of ASN protein was lower in
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the female hippocampus than in that
of males (p :c:; 0.05; Figure 5). The expression of ASN protein in the aged
female hippocampus was higher than
that in adult female rats (p :c:; 0.05),
and was unaltered with aging in
males (Figure 5).
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It is well known that females and
males display different rates of aging,
while others have postulated that the
interaction of sex with age may play a
role in the development of disease [2,
34-36]. Using the F344BN rat model
[5, 10, 29], we have herein demonstrated significant sex-associated differences in the regulation of iron- and
neurodegeneration-related molecules
in the hippocampus. These data support the possibility that sex may play
a role in the development of age- and
iron-related
neurodegenerative
diseases.

F-6

F-30

M-6

M-33

Figure 3 Iron-regulatory protein (IRPI) mRNA expression in
the hippocampus in adult and aged female and male F344BN
rats (F-6 and F-30: 6- and 30-month-old female rats; M-6
and M-33: 6- and 33-month-old male rats) Data are means±
SEM (n = 6 per group). 1here is a gender effect (p :c:;0.05), but
there is neither an age (p = 0.56) nor an interaction between
gender and age (p = 0. 86). *:gender difference (p :c:; 0. 05) within the same age.
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*

*

2
1.5

HOI is an inducible heme oxygenase
that functions to degrade the prooxidant heme in response to stress.
0.5
Consistent with previous work [37],
we demonstrated that the expression
ofHOI is increased with age (Figure
F-6
M-33
F-30
M-6
1). We also found, for both adult and
Figure 4 Alpha-synuclein (ASN) mRNA expression in the hipaged rats, that HOI expression is
pocampus in adult and aged female and male F344BN rats
(F-6 and F-30: 6- and 30-month-old female rats; M-6 and
higher in the female hippocampus
M-33: 6- and 33-month-old male rats) Data are means ±
when compared to that observed in
SEM (n = 6 per group). 1here is a difference by gender (p :c:;
the age-matched male hippocampus
0.05), but there is neither an age effect (p = 0.31) nor an interaction between gender and age (p = 0.49). *:gender difference
(Figure 1). As an important antioxi(p :c:; 0.05) within the same age.
dant enzyme and a dynamic sensor of
cellular oxidative stress, the increased
HOI expression in the aged female
oxidative stress, as it mediates the formation of free
hippocampus may protect cells by degrading prooxidant metalloporphyrins. This finding, if presradicals [39, 40]. Although no significant different, may help to explain why some have suggested
ences in total iron level between male and female
that the female rat brain exhibits better control of
brains of Sprague-Dawley rats have been reported
oxidative stress balance than does the male brain in
[11], it is worthwhile to note that it is free ferrous
animals of similar ages [11, 38].
iron that mediates the formation of free radicals
[39, 40]. When bound to the iron storage protein
Free ferrous iron generated from the HOI-induced
ferritin, free ferrous iron is converted to a non-toxic
degradation of heme is a potential stimulator of
form [I8, 4I]. Given that the expression ofFTH is
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functions to inhibit the binding of
IRPI to IRE thereby allowing translation and synthesis of proteins [I8,
ASN
26]. Additional data from in vitro experiments has suggested that knockGAPDH
down of IRPI results in increased expression of both ASN mRNA and
120
protein in human SK-N-SH cells
G)
[42]. In the current study, we obu.100
served higher expression of HOI
(Figure 1) and FTH (Figure 2) in
~ 80
the female hippocampus, which is
:II
.c
consistent
with the possibility of dic( 60
minished free iron content. This find> 40
ing, if present, suggests a higher bind1a
ing ofiRPI to the IRE in the 5'UTR
~ 20
of target mRNA and inhibition of
target protein translation [I8, 26].
0
This possibility is supported by our
F-6
F-30
M-6
M-33
findings of decreased ASN mRNA
and protein in the female hippocampus (Figures 4 and 5, respectively).
Figure 5. Alpha-synuclein (ASN) protein expression in the hippocamAlthough the results of the present
pus in adult and aged female and male F344BN rats (F-6 and F-30:
6- and 30-month-oldfemale rats; M- 6 and M-33: 6- and 33-monthstudy alone are not sufficient to deterold male rats). Data are means± SEM (n = 6 per group). 1here are
mine whether there is a causative link
gender (p :c:; 0.05) and age (p :c:; 0.05) differences. f: age difference (p :c:;
between the development of neurode0.05) within the same gender; *:gender difference (p :c:; 0.05) within
the same age.
generative diseases, ASN expression,
and iron dysregulation, they may prohigher in the female hippocampus than in that of
vide insight into the mechanism(s) potentially reage-matched males (Figure 2), it is possible that
sponsible for the significantly higher incidence of
the female brain is better able to "capture" free iron
Parkinson's disease in men than in women [2].
from tissues, thus potentially protecting against its
Further study using pharmacological intervention
deleterious effects and the associated oxidative
and/or transgenic animals will no doubt shed light
damage. Future research that includes the meaon the definitive mechanism.
surement of free ferrous iron in hippocampal tissue
In summary, this study demonstrates sex- and agewill provide valuable information for testing this
dependent differences in the expression of iron-rehypothesis.
lated molecules (HOI, FTH, and IRPI) in the hipIt has been shown that iron can induce the misfoldpocampus of F344BN rats. These differences are
ing and aggregation of ASN protein to form the
linked to differences in the expression of ASN, a
main component of the intracytoplasmic Lewy
critical protein related to the development of neubodies, an abnormal protein cluster found in the
rodegenerative diseases. These data provide the mobrains of Parkinson's patients [22-25]. Interestingly
lecular basis for further study to address the effects
an IRE-like stem-loop structure has recently been
of sex, iron accumulation, and advanced age on the
found in the 5'UTR of ASN mRNA [26]. Studies
pathological development of neurodegenerative
have shown that when intracellular free iron condiseases.
tent is low, IRPI binds to the IRE in the 5'UTR of
mRNA and inhibits its translation. Conversely, inAcknowledgements
This work was supported by National Science Foundation
creased intracellular free 1ron concentration
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